Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Ketamine vs. Combination vs. IM Ketamine for Pediatric Burn Sedation
NCT07086690Phase 1Active, not recruiting
- Sponsor
- Ain Shams University
- Start
- Apr 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ketamine and dexmedetomidine in burn injury (3 arms), sponsored by Ain Shams University. Primary endpoint: University of Michigan Sedation Scale at 5 months. Started Apr 2025; status: active, not recruiting.
02
Drugs
ketaminedexmedetomidine
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT07086690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07086690.